Efficacy and Safety of AVP-21D9, an Anthrax Monoclonal Antibody, in Animal Models and Humans

Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Timely administration of antibiotics approved for the treatment of anthrax disease may prevent associated morbidity and mortality. However, any delay in initiating antimicrobial therapy may result in inc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Malkevich, Nina V., Hopkins, Robert J., Bernton, Edward, Meister, Gabriel T., Vela, Eric M., Atiee, George, Johnson, Virginia, Nabors, Gary S., Aimes, Ronald T., Ionin, Boris, Skiadopoulos, Mario H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068543/
https://ncbi.nlm.nih.gov/pubmed/24733473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02295-13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi